Close

ISIS (ISIS) Data Encouraging; Infants Coming Soon, Says Deutsche Bank

February 21, 2014 10:44 AM EST Send to a Friend
Deutsche Bank reiterated a Buy rating on ISIS Pharmaceuticals (NASDAQ: ISIS) with a price target of $60.00. Comments follow interim ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login